ArticleJournal of cardiology cases2026
Hemorrhaged left atrial myxoma presenting with acute heart failure: A case report.
Article in Journal of cardiology cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left atrial myxoma is the most common primary cardiac tumor, although intratumoral hemorrhage remains exceedingly rare. We recently treated a 55-year-old man with a 37-year smoking history who presented with progressive dyspnea and leg edema caused by acute heart failure. Echocardiography revealed a large, pedunculated left atrial mass (54 × 27 mm) protruding into the left ventricle during diastole, causing functional mitral stenosis, as well as moderate mitral and tricuspid regurgitation. Contrast-enhanced computed tomography revealed a 30 × 46 mm intracardiac mass without definite feeding vessels or signs of hemorrhage. The patient underwent semi-urgent surgery 1 week after diagnosis, with complete tumor excision and concomitant mitral and tricuspid annuloplasty. Histopathological examination revealed a 5.5 cm myxoid tumor containing multiple intratumoral hemorrhagic foci with hemosiderin deposition, consistent with hemorrhagic myxoma. The postoperative course was uneventful. Intratumoral bleeding within a myxoma may result from rupture of fragile neovessels, potentially leading to sudden enlargement and mitral inflow obstruction. Awareness of this rare condition is essential for timely clinical recognition and appropriate surgical decision-making in patients with deteriorating left atrial myxoma. Learning objective: To highlight that intratumoral hemorrhage in left atrial myxoma, although rare, can cause rapid tumor enlargement and acute mitral inflow obstruction. Recognition of early symptoms, such as unexplained cough and dyspnea, may facilitate timely diagnosis and prompt surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.